Delivery Order SPE2DB22D3301-SPE2DB25FZ1DW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $77,327.57 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count packaging) on July 28, 2025. This competitively awarded, firm fixed-price delivery order, which is not subject to any set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $103,162.18 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a $3,744.81 delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Gilenya 0.5 mg capsules (30-count units). The contract, which is non-set-aside and competitively awarded, carries a firm fixed price and is scheduled for completion by June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,597.07, is for the supply of Gilenya 0.5 mg capsules. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order, valued at $20,129.07, has a completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under a set-aside designation. In addition to this specific award, Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency Troop Support Medical awarded a $12,350.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of the 0.5 mg dosage of Gilenya, to be delivered to their location in Conshohocken, Pennsylvania between August 11-14, 2023. Amerisourcebergen will fulfill the order for the multiple sclerosis drug from their corporate office division. The delivery order was issued against an existing DLA medical supply vehicle and no subcontractors or...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,852.32, is for the supply of Gilenya 0.5 mg capsules. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,750.55 firm fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules, with a completion date of September 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a $3,038 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 4561412045 Gilenya 0.5 mg capsules. The order is for 30 capsules to be delivered to a facility in Conshohocken, Pennsylvania by July 6, 2023. AmerisourceBergen will supply the multiple sclerosis medication to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, under an indefinite-delivery/indefinite-quantity contract...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1DWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $110,199.71 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) under a firm fixed price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location, leveraging its established role as a critical pharmaceutical distributor for federal medical procurement. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive portfolio of therapeutic product deliveries, positions it as a key vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $110.2k | 9/17/25 |